Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Hair cortisol concentrations in chronic central serous chorioretinopathy.

van Haalen FM, van Dijk EHC, Savas M, Brinks J, Dekkers OM, Dijkman G, van Rossum EFC, Biermasz NR, Boon CJF, Pereira AM.

Acta Ophthalmol. 2019 Oct 13. doi: 10.1111/aos.14269. [Epub ahead of print]

PMID:
31608607
2.

Central serous chorioretinopathy: Towards an evidence-based treatment guideline.

van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ, Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF.

Prog Retin Eye Res. 2019 Jul 15:100770. doi: 10.1016/j.preteyeres.2019.07.003. [Epub ahead of print] Review.

3.

Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.

van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, MacLaren RE, Querques G, Fauser S, Hoyng CB, Downes SM, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1419-1425. doi: 10.1007/s00417-019-04333-y. Epub 2019 May 23.

PMID:
31123815
4.

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy.

Hanumunthadu D, van Dijk EHC, Dumpala S, Rajesh B, Jabeen A, Jabeen A, Ansari M, Mehta P, Shah S, Sarvaiya C, Meyerle C, Wu L, Banker A, Boon CJ, Chhablani J.

J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):164-170. doi: 10.4103/jovr.jovr_152_17.

5.

Human iPSC-Derived Retinas Recapitulate the Fetal CRB1 CRB2 Complex Formation and Demonstrate that Photoreceptors and Müller Glia Are Targets of AAV5.

Quinn PM, Buck TM, Mulder AA, Ohonin C, Alves CH, Vos RM, Bialecka M, van Herwaarden T, van Dijk EHC, Talib M, Freund C, Mikkers HMM, Hoeben RC, Goumans MJ, Boon CJF, Koster AJ, Chuva de Sousa Lopes SM, Jost CR, Wijnholds J.

Stem Cell Reports. 2019 May 14;12(5):906-919. doi: 10.1016/j.stemcr.2019.03.002. Epub 2019 Apr 4.

6.

Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.

van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF.

Am J Ophthalmol. 2019 Sep;205:1-10. doi: 10.1016/j.ajo.2019.03.025. Epub 2019 Apr 3.

PMID:
30951686
7.

Reply.

van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF.

Ophthalmology. 2019 Apr;126(4):e30-e31. doi: 10.1016/j.ophtha.2018.11.005. No abstract available.

PMID:
30910048
8.

Exome sequencing in families with chronic central serous chorioretinopathy.

Schellevis RL, van Dijk EHC, Breukink MB, Keunen JEE, Santen GWE, Hoyng CB, de Jong EK, Boon CJF, den Hollander AI.

Mol Genet Genomic Med. 2019 Apr;7(4):e00576. doi: 10.1002/mgg3.576. Epub 2019 Feb 6.

9.

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy.

Mohabati D, van Dijk EH, van Rijssen TJ, de Jong EK, Breukink MB, Martinez-Ciriano JP, Dijkman G, Hoyng CB, Fauser S, Yzer S, Boon CJ.

Clin Ophthalmol. 2018 Oct 24;12:2167-2176. doi: 10.2147/OPTH.S174573. eCollection 2018.

10.

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy.

Brinks J, van Dijk EHC, Habeeb M, Nikolaou A, Tsonaka R, Peters HAB, Sips HCM, van de Merbel AF, de Jong EK, Notenboom RGE, Kielbasa SM, van der Maarel SM, Quax PHA, Meijer OC, Boon CJF.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5682-5692. doi: 10.1167/iovs.18-25054.

PMID:
30489628
11.

Reply.

van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Keunen JEE, Groenewoud JMM, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF.

Ophthalmology. 2019 Jan;126(1):e11. doi: 10.1016/j.ophtha.2018.06.038. Epub 2018 Nov 22. No abstract available.

PMID:
30470545
12.

Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy.

van Haalen FM, van Dijk EHC, Andela CD, Dijkman G, Biermasz NR, Pereira AM, Boon CJF.

Acta Ophthalmol. 2019 Jun;97(4):e572-e579. doi: 10.1111/aos.13952. Epub 2018 Oct 30.

PMID:
30378259
13.

GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.

Mohabati D, Schellevis RL, van Dijk EHC, Altay L, Fauser S, Hoyng CB, De Jong EK, Boon CJF, Yzer S.

Retina. 2018 Oct 8. doi: 10.1097/IAE.0000000000002333. [Epub ahead of print]

PMID:
30300269
14.

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy.

van Rijssen TJ, Mohabati D, Dijkman G, Theelen T, de Jong EK, van Dijk EHC, Boon CJF.

PLoS One. 2018 Aug 24;13(8):e0202549. doi: 10.1371/journal.pone.0202549. eCollection 2018.

15.

Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.

Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK.

JAMA Ophthalmol. 2018 Oct 1;136(10):1128-1136. doi: 10.1001/jamaophthalmol.2018.3190.

16.

Discrepancy in current central serous chorioretinopathy classification.

Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.

Br J Ophthalmol. 2019 Jun;103(6):737-742. doi: 10.1136/bjophthalmol-2018-312435. Epub 2018 Jul 12.

PMID:
30002069
17.

Gender variation in central serous chorioretinopathy.

Hanumunthadu D, Van Dijk EHC, Gangakhedkar S, Goud A, Cheung CMG, Cherfan D, Sarvaiya C, Banker A, Meyerle C, Boon CJ, Singh R, Wu L, Chhablani J.

Eye (Lond). 2018 Nov;32(11):1703-1709. doi: 10.1038/s41433-018-0163-7. Epub 2018 Jul 9.

18.

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy.

Mohabati D, van Rijssen TJ, van Dijk EH, Luyten GP, Missotten TO, Hoyng CB, Yzer S, Boon CJ.

Clin Ophthalmol. 2018 Jun 7;12:1061-1070. doi: 10.2147/OPTH.S160956. eCollection 2018.

19.

Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial.

van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF.

Ophthalmology. 2018 Oct;125(10):1547-1555. doi: 10.1016/j.ophtha.2018.04.021. Epub 2018 Jun 14.

20.

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.

van Rijssen TJ, van Dijk EHC, Dijkman G, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1395-1402. doi: 10.1007/s00417-018-4003-z. Epub 2018 May 7.

21.

Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.

van Haalen FM, van Dijk EHC, Dekkers OM, Bizino MB, Dijkman G, Biermasz NR, Boon CJF, Pereira AM.

Front Endocrinol (Lausanne). 2018 Feb 20;9:39. doi: 10.3389/fendo.2018.00039. eCollection 2018.

22.

Pimasertib-associated ophthalmological adverse events.

van Dijk EHC, Kruit WHJ, Jager MJ, Luyten GPM, Vingerling JR, Boon CJF.

Acta Ophthalmol. 2018 Nov;96(7):712-718. doi: 10.1111/aos.13677. Epub 2018 Jan 16.

23.

FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY.

van Dijk EHC, Schellevis RL, Breukink MB, Mohabati D, Dijkman G, Keunen JEE, Yzer S, den Hollander AI, Hoyng CB, de Jong EK, Boon CJF.

Retina. 2019 Feb;39(2):398-407. doi: 10.1097/IAE.0000000000001966.

PMID:
29190234
24.

AAV Serotype Testing on Cultured Human Donor Retinal Explants.

Buck TM, Pellissier LP, Vos RM, van Dijk EHC, Boon CJF, Wijnholds J.

Methods Mol Biol. 2018;1715:275-288. doi: 10.1007/978-1-4939-7522-8_20.

PMID:
29188521
25.

Postoperative aqueous humour flare as a surrogate marker for proliferative vitreoretinopathy development.

Mulder VC, van Dijk EHC, van Meurs IA, La Heij EC, van Meurs JC.

Acta Ophthalmol. 2018 Mar;96(2):192-196. doi: 10.1111/aos.13560. Epub 2017 Oct 25.

26.

Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.

van Dijk EHC, Soonawala D, Rooth V, Hoyng CB, Meijer OC, de Vries APJ, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2443-2449. doi: 10.1007/s00417-017-3823-6. Epub 2017 Oct 23.

27.

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.

van Dijk EHC, Dijkman G, Boon CJF.

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2029-2035. doi: 10.1007/s00417-017-3720-z. Epub 2017 Jul 3.

28.

Systemic complement activation in central serous chorioretinopathy.

van Dijk EHC, Tsonaka R, Klar-Mohamad N, Wouters D, de Vries APJ, de Jong EK, van Kooten C, Boon CJF.

PLoS One. 2017 Jul 3;12(7):e0180312. doi: 10.1371/journal.pone.0180312. eCollection 2017.

29.

Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.

Ten Berge JCEM, van Dijk EHC, Schreurs MWJ, Vermeer J, Boon CJF, Rothova A.

Acta Ophthalmol. 2018 Feb;96(1):56-62. doi: 10.1111/aos.13445. Epub 2017 Apr 26.

30.

Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy.

van Dijk EHC, Schellevis RL, van Bergen MGJM, Breukink MB, Altay L, Scholz P, Fauser S, Meijer OC, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK.

JAMA Ophthalmol. 2017 May 1;135(5):446-451. doi: 10.1001/jamaophthalmol.2017.0245.

31.

Preoperative aqueous humour flare values do not predict proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.

Mulder VC, Tode J, van Dijk EH, Purtskhvanidze K, Roider J, van Meurs JC, Treumer F.

Br J Ophthalmol. 2017 Sep;101(9):1285-1289. doi: 10.1136/bjophthalmol-2016-309134. Epub 2017 Jan 11.

PMID:
28077370
32.

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome.

Chung WH, van Dijk EH, Mohabati D, Dijkman G, Yzer S, de Jong EK, Fauser S, Schlingemann RO, Hoyng CB, Boon CJ.

Clin Ophthalmol. 2016 Dec 21;11:63-70. doi: 10.2147/OPTH.S122568. eCollection 2017.

33.

SHORT-TERM FINDINGS ON OPTICAL COHERENCE TOMOGRAPHY AND MICROPERIMETRY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY PATIENTS TREATED WITH HALF-DOSE PHOTODYNAMIC THERAPY.

van Dijk EHC, Dijkman G, Theelen T, Hoyng CB, Boon CJF.

Retin Cases Brief Rep. 2018 Fall;12(4):266-271. doi: 10.1097/ICB.0000000000000498.

PMID:
27997459
34.

Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy'.

van Dijk EH, Boon CJ.

Eye (Lond). 2017 Feb;31(2):345-346. doi: 10.1038/eye.2016.242. Epub 2016 Nov 4. No abstract available.

35.

Central serous chorioretinopathy in primary hyperaldosteronism.

van Dijk EH, Nijhoff MF, de Jong EK, Meijer OC, de Vries AP, Boon CJ.

Graefes Arch Clin Exp Ophthalmol. 2016 Oct;254(10):2033-2042. Epub 2016 Jul 8.

36.

Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study.

Breukink MB, Mohabati D, van Dijk EH, den Hollander AI, de Jong EK, Dijkman G, Keunen JE, Hoyng CB, Boon CJ.

Acta Ophthalmol. 2016 Sep;94(6):565-72. doi: 10.1111/aos.13059. Epub 2016 May 6.

37.

Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients.

van Dijk EH, Duits DE, Versluis M, Luyten GP, Bergen AA, Kapiteijn EW, de Lange MJ, Boon CJ, van der Velden PA.

Medicine (Baltimore). 2016 May;95(18):e3457. doi: 10.1097/MD.0000000000003457.

38.

Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome.

van Dijk EH, Dijkman G, Biermasz NR, van Haalen FM, Pereira AM, Boon CJ.

Eur J Ophthalmol. 2016 Aug 4;26(5):442-8. doi: 10.5301/ejo.5000790. Epub 2016 Apr 22.

PMID:
27135093
39.

Behçet's disease, hospital-based prevalence and manifestations in the Rotterdam area.

Kappen JH, van Dijk EH, Baak-Dijkstra M, van Daele PL, Lam-Tse WK, van Hagen PM, van Laar JA.

Neth J Med. 2015 Dec;73(10):471-7.

40.

Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.

Breukink MB, Downes SM, Querques G, van Dijk EHC, den Hollander AI, Blanco-Garavito R, Keunen JEE, Souied EH, MacLaren RE, Hoyng CB, Fauser S, Boon CJF.

Trials. 2015 Sep 21;16:419. doi: 10.1186/s13063-015-0939-z.

41.

Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.

van Dijk EH, van Herpen CM, Marinkovic M, Haanen JB, Amundson D, Luyten GP, Jager MJ, Kapiteijn EH, Keunen JE, Adamus G, Boon CJ.

Ophthalmology. 2015 Sep;122(9):1907-16. doi: 10.1016/j.ophtha.2015.05.027. Epub 2015 Jun 26.

PMID:
26123090
42.

Synthesis and properties of an anthraquinone-based redox switch for molecular electronics.

van Dijk EH, Myles DJ, van der Veen MH, Hummelen JC.

Org Lett. 2006 May 25;8(11):2333-6.

PMID:
16706519
43.

Effects of hypothermia and gender on survival and behavior after perinatal asphyxia in rats.

Loidl CF, Gavilanes AW, Van Dijk EH, Vreuls W, Blokland A, Vles JS, Steinbusch HW, Blanco CE.

Physiol Behav. 2000 Jan;68(3):263-9.

PMID:
10716534
44.

Hypothermia during or after severe perinatal asphyxia prevents increase in cyclic GMP-related nitric oxide levels in the newborn rat striatum.

Loidl CF, De Vente J, van Ittersum MM, van Dijk EH, Vles JS, Steinbusch HW, Blanco CE.

Brain Res. 1998 Apr 27;791(1-2):303-7.

PMID:
9593957

Supplemental Content

Loading ...
Support Center